892 related articles for article (PubMed ID: 23688540)
41. Promoting appropriate drug use through the application of the Spanish drug-related problem classification system in the primary care setting.
Gómez MA; Villafaina A; Hernández J; Salgado RM; González MA; Rodríguez J; Martínez de la Concha M; Tarriño A; Gervasini G; Carrillo JA
Ann Pharmacother; 2009 Feb; 43(2):339-46. PubMed ID: 19193590
[TBL] [Abstract][Full Text] [Related]
42. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0).
;
J Am Pharm Assoc (2003); 2008; 48(3):341-53. PubMed ID: 18595820
[TBL] [Abstract][Full Text] [Related]
43. Community pharmacist led medication reviews in the UK: A scoping review of the medicines use review and the new medicine service literatures.
Stewart D; Whittlesea C; Dhital R; Newbould L; McCambridge J
Res Social Adm Pharm; 2020 Feb; 16(2):111-122. PubMed ID: 31085141
[TBL] [Abstract][Full Text] [Related]
44. Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation.
Wells KM; Thornley T; Boyd MJ; Boardman HF
Res Social Adm Pharm; 2014; 10(1):58-71. PubMed ID: 23608701
[TBL] [Abstract][Full Text] [Related]
45. A patient-centered pharmacy services model of HIV patient care in community pharmacy settings: a theoretical and empirical framework.
Kibicho J; Owczarzak J
AIDS Patient Care STDS; 2012 Jan; 26(1):20-8. PubMed ID: 22149903
[TBL] [Abstract][Full Text] [Related]
46. Assessment of clinical pharmacists' interventions in French hospitals: results of a multicenter study.
Bedouch P; Charpiat B; Conort O; Rose FX; Escofier L; Juste M; Roubille R; Allenet B
Ann Pharmacother; 2008 Jul; 42(7):1095-103. PubMed ID: 18559955
[TBL] [Abstract][Full Text] [Related]
47. Retrospective analysis of estimated cost avoidance following pharmacist-provided medication therapy management services.
Branham AR; Katz AJ; Moose JS; Ferreri SP; Farley JF; Marciniak MW
J Pharm Pract; 2013 Aug; 26(4):420-7. PubMed ID: 23178415
[TBL] [Abstract][Full Text] [Related]
48. Pharmacy performance while providing continuous medication monitoring.
Doucette WR; McDonough RP; Herald F; Goedken A; Funk J; Deninger MJ
J Am Pharm Assoc (2003); 2017; 57(6):692-697. PubMed ID: 28844583
[TBL] [Abstract][Full Text] [Related]
49. Collaboration between hospital and community pharmacists to address drug-related problems: The HomeCoMe-program.
Ensing HT; Koster ES; Dubero DJ; van Dooren AA; Bouvy ML
Res Social Adm Pharm; 2019 Mar; 15(3):267-278. PubMed ID: 29773308
[TBL] [Abstract][Full Text] [Related]
50. A clinical knowledge measurement tool to assess the ability of community pharmacists to detect drug-related problems.
Williams M; Peterson GM; Tenni PC; Bindoff IK
Int J Pharm Pract; 2012 Aug; 20(4):238-48. PubMed ID: 22775520
[TBL] [Abstract][Full Text] [Related]
51. Strategies for community-based medication management services in value-based health plans.
Smith MA; Spiggle S; McConnell B
Res Social Adm Pharm; 2017; 13(1):48-62. PubMed ID: 26904962
[TBL] [Abstract][Full Text] [Related]
52. The medication experience: preliminary evidence of its value for patient education and counseling on chronic medications.
Shoemaker SJ; Ramalho de Oliveira D; Alves M; Ekstrand M
Patient Educ Couns; 2011 Jun; 83(3):443-50. PubMed ID: 21435815
[TBL] [Abstract][Full Text] [Related]
53. Pharmaceutical care in community pharmacies: practice and research in Sweden.
Westerlund LT; Björk HT
Ann Pharmacother; 2006 Jun; 40(6):1162-9. PubMed ID: 16735653
[TBL] [Abstract][Full Text] [Related]
54. Continuous Medication Monitoring (CoMM): A foundational model to support the clinical work of community pharmacists.
Goedken AM; Butler CM; McDonough RP; Deninger MJ; Doucette WR
Res Social Adm Pharm; 2018 Jan; 14(1):106-111. PubMed ID: 28087207
[TBL] [Abstract][Full Text] [Related]
55. Diabetes Medication Assistance Service: the pharmacist's role in supporting patient self-management of type 2 diabetes (T2DM) in Australia.
Mitchell B; Armour C; Lee M; Song YJ; Stewart K; Peterson G; Hughes J; Smith L; Krass I
Patient Educ Couns; 2011 Jun; 83(3):288-94. PubMed ID: 21616627
[TBL] [Abstract][Full Text] [Related]
56. Development and validation of the PAIR (Pharmacotherapy Assessment in Chronic Renal Disease) criteria to assess medication safety and use issues in patients with CKD.
Desrochers JF; Lemieux JP; Morin-Bélanger C; Paradis FS; Lord A; Bell R; Berbiche D; Bárcena PQ; Séguin NC; Desforges K; Legris MÈ; Sauvé P; Lalonde L
Am J Kidney Dis; 2011 Oct; 58(4):527-35. PubMed ID: 21778005
[TBL] [Abstract][Full Text] [Related]
57. Practical evaluation of the drug-related problem management process in Swiss community pharmacies.
Krähenbühl JM; Kremer B; Guignard B; Bugnon O
Pharm World Sci; 2008 Dec; 30(6):777-86. PubMed ID: 18392732
[TBL] [Abstract][Full Text] [Related]
58. Does hospitalization influence patients' medication adherence and community pharmacists' interventions?
Beloin-Jubinville B; Joly-Mischlich T; Rouleau ED; Noiseux P; Blais L; Forget A; Beauchesne MF
Ann Pharmacother; 2013 Sep; 47(9):1143-52. PubMed ID: 24259729
[TBL] [Abstract][Full Text] [Related]
59. Medicine-related questions handled by community pharmacists: an exploratory study.
Rutter PM; Warren S; Rutter J
Int J Pharm Pract; 2009 Oct; 17(5):313-5. PubMed ID: 20214274
[TBL] [Abstract][Full Text] [Related]
60. Drug-related problems in prescribed medicines in Germany at the time of dispensing.
Nicolas A; Eickhoff C; Griese N; Schulz M
Int J Clin Pharm; 2013 Jun; 35(3):476-82. PubMed ID: 23605073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
